California Home
Welcome to California - images of Golden Gate Bridge, ocean sunset, waterfall, flowers, and city skyline

OEHHA Home

Air

About OEHHA

Children's Health

Ecotoxicology

Fish

Pesticides

Proposition 65

Public Information

Risk Assessment

Water

Reference Links

Help!

Site Map

OEHHA Listserver

Prop. 65 Listserver

Contact OEHHA Staff

OEHHA link to home page
Proposition 65 - Administrative Listing: Requests for Information
Request for Information on a Chemical to be Considered by the OEHHA Science Advisory Board's Carcinogen Identification Committee: Rosuvastatin calcium - EXTENSION OF PUBLIC COMMENT PERIOD
[11/21/03]

go to download area

On September 26, 2003, the Office of Environmental Health Hazard Assessment (OEHHA) published a notice in the California Regulatory Notice Register (Register 03, No. 39) soliciting information that may be relevant to the evaluation of carcinogenicity of rosuvastatin calcium. A solicitation of information for six other statin drugs (atorvastatin calcium, cerivastatin sodium, fluvastatin sodium, lovastatin, pravastatin sodium, and simvastatin) has already been completed. The Carcinogen Identification Committee (CIC) at its December 17, 2002, meeting recommended that OEHHA, as resources are available, prepare hazard identification documents for each of the statin drugs and present them to the CIC at a future meeting. The CIC at that time would consider each of the statin drugs for possible listing within the context of Proposition 65. Information being solicited in the September 26 request is to assist in the development of the hazard identification document for rosuvastatin calcium.

The solicitation for information announced on September 26 was to close on November 25, 2003. OEHHA has received a request from an interested party that an extension of the solicitation period for rosuvastatin calcium be provided to allow for the submittal of complete and relevant information. OEHHA hereby extends the public comment period to 5 p.m., Friday, January 9, 2004 for rosuvastatin calcium. Interested parties or members of the public wishing to provide information relevant to the assessment of carcinogenicity for this chemical should forward such information including, but not limited to, cancer bioassays, cancer epidemiological studies, genotoxicity testing, pharmacokinetics, biomarkers, effects on biochemical and physiological processes in humans, and clinical histopathologic information exclusive of that related to muscle damage, to the address given below. Relevant information should be sent in triplicate by mail or fax to:

Cynthia Oshita
Office of Environmental Health Hazard Assessment
Proposition 65 Implementation
P.O. Box 4010
1001 I Street, 19th floor
Sacramento, California 95812-4010
FAX: (916) 323-8803 Telephone: (916) 445-6900

In order to be considered, the relevant information must be postmarked (if sent by mail) or received at OEHHA (if delivered in person or sent by FAX) by 5:00 p.m. on Friday, January 9, 2004.

Follow this link to download a copy of this notice as a pdf file.


You will need the free program Adobe Acrobat Reader to view or print PDF files Go to the Adobe web site

For questions regarding Proposition 65, please contact the Cynthia Oshita in the Proposition 65 Implementation Program

For help with this web site please contact the Web Mistress



OEHHA My CA
Proposition 65 Links


What's New

Current List of Chemicals

Safe Harbor Numbers
(NSRLs/MADLs)

Calendar

General Background

Proposition 65 Frequently Asked Questions

Workshop/Meeting Materials

CRNR Notices

Administrative Listing Mechanisms

State's Qualified Experts Mechanism

Law/Regulations/ Rulemaking Activity

Policy and Procedure documents

Toxicity Criteria Database